John et al. developed CAR T-cells against leukocyte immunoglobulin-like receptor B4 (LILRB4), which is highly expressed on monocytic AML cells and is known to cause T-cell suppression and AML tissue infiltration. This evidence concerns the gene LILRB4 and acute myeloid leukemia.